Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP9 | Q86TI2 | 8/20 | 0.50 |
| ▸ | DPP4 | P27487 | 7/20 | 0.50 |
| ▸ | DPP8 | Q6V1X1 | 7/20 | 0.50 |
| ▸ | DPP7 | Q9UHL4 | 6/20 | 0.50 |
| ▸ | CTSC | P53634 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CTSH | P09668 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 1/20 | 0.39 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10076136 | 1.00 | DPP9 (0.50) | DPP9DPP4DPP8DPP7CTSC | |
| SCHEMBL13829067 | 0.82 | DPP7 (0.56) | DPP9DPP4DPP8DPP7SLC15A1 | |
| SCHEMBL23866587 | 0.81 | DPP4 (0.39) | DPP9DPP4DPP8DPP7SLC15A1 | |
| SCHEMBL20649207 | 0.81 | DPP4 (0.39) | DPP9DPP4DPP8DPP7SLC15A1 | |
| SCHEMBL24221417 | 0.81 | DPP9 (0.49) | DPP9DPP4DPP8DPP7ALDH1A1 | |
| SCHEMBL12269108 | 0.81 | DPP4 (0.39) | DPP9DPP4DPP8DPP7SLC15A1 | |
| SCHEMBL17868351 | 0.80 | MME (0.56) | DPP9DPP4DPP8DPP7CTSC | |
| SCHEMBL21748461 | 0.80 | MME (0.56) | DPP9DPP4DPP8DPP7CTSC | |
| SCHEMBL19502439 | 0.80 | DPP4 (0.46) | DPP9DPP4DPP8DPP7CTSC | |
| SCHEMBL21034312 | 0.79 | PTGS1 (0.46) | DPP9DPP4DPP8DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117105803-A | Preparation method of gamma-aminobutanamide | 国药集团化学试剂有限公司 | 2023-11-24 | — | — | CN | disclosed |
| EP-3604457-B1 | AQUEOUS INK COMPOSITION, INK SET, IMAGE FORMING METHOD, AND RESIN MICROPARTICLES FOR INK | FUJIFILM CORP (JP) | 2022-02-09 | — | — | EP | disclosed |
| EP-3604457-A1 | AQUEOUS INK COMPOSITION, INK SET, IMAGE FORMING METHOD, AND RESIN FINE PARTICLES FOR INKS | FUJIFILM Corporation (JP) | 2020-02-05 | — | — | EP | disclosed |
| US-9872919-B2 | Prodrugs for selective anticancer therapy | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2018-01-23 | — | — | US | disclosed |
| US-9764037-B2 | Conjugate compounds | VICTORIA LINK LIMITED (NZ) | 2017-09-19 | — | — | US | disclosed |
| US-20170119875-A1 | AMINO SPHINGOGLYCOLIPID ANALOGUES | VICTORIA LINK LIMITED (NZ) | 2017-05-04 | — | — | US | disclosed |
| US-20150352219-A1 | CONJUGATE COMPOUNDS | VICTORIA LINK LIMITED (NZ) | 2015-12-10 | — | — | US | disclosed |
| US-20150224208-A1 | NOVEL PRODRUGS FOR SELECTIVE ANTICANCER THERAPY | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2015-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170119875-A1 | AMINO SPHINGOGLYCOLIPID ANALOGUES | SGMS1, ENPP2, SGMS2 | DPP9 142/4885DPP4 76/4885DPP8 80/4885 |
| US-20150224208-A1 | NOVEL PRODRUGS FOR SELECTIVE ANTICANCER THERAPY | NR4A3, ORC3, NTSR1 | DPP9 3497/4885DPP4 1548/4885DPP8 1728/4885 |
| US-20150352219-A1 | CONJUGATE COMPOUNDS | SGMS1, SGMS2, ENPP2 | DPP9 471/4885DPP4 449/4885DPP8 446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.